Company Comparison
Blueprint Medicines vs 54gene
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | Blueprint Medicines | 54gene |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | Cambridge, MA | Lagos, Nigeria |
| Founded | 2011 | 2019 |
| Status | Active | Active |
| Last Funding Stage | IPO | Series B |
| Total Funding | $676M | $45M |
| Valuation | — | — |
What They Build
Blueprint Medicines
Precision medicine company developing targeted therapies for cancer and rare diseases using genomics-based drug discovery.
54gene
African genomics research company advancing precision medicine through genetic research focused on African populations.
Key Investors
Blueprint Medicines
Sector Overlap
Both Blueprint Medicines and 54gene operate in Biotech.
Browse all Biotech companies →Websites
The operating system for private capital.
Archstone runs the back office for venture, PE, real estate, and credit funds — LP reporting, capital calls, portfolio tracking, and fund accounting, in one platform. Now in alpha.
Now in alpha with select funds. 14-day trial available.